Open Access
Research Article
Issue
Parasite
Volume 27, 2020
Article Number 7
Number of page(s) 9
DOI https://doi.org/10.1051/parasite/2020006
Published online 07 February 2020
  1. Chapey E, Wallon M, Debize G, Rabilloud M, Peyron F. 2010. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. Journal of Clinical Microbiology, 48, 41–45. [CrossRef] [PubMed] [Google Scholar]
  2. Chapey E, Wallon M, L’Ollivier C, Piarroux R, Peyron F. 2015. Place of interferon-γ assay for diagnosis of congenital toxoplasmosis. Pediatric Infectious Disease Journal, 34, 1407–1409. [Google Scholar]
  3. Christie E, Dubey JP. 1977. Cross-immunity between Hammondia and Toxoplasma infections in mice and hamsters. Infection and Immunity, 18, 412–415. [CrossRef] [PubMed] [Google Scholar]
  4. Chuang Y-C, Chen J-Y, Ji D-D, Su P-H. 2012. Congenital toxoplasmosis in a neonate with significant neurologic manifestations. Journal of the Formosan Medical Association, 111, 232–233. [Google Scholar]
  5. Ciardelli L, Meroni V, Avanzini MA, Bollani L, Tinelli C, Garofoli F, Gasparoni A, Stronati M. 2008. Early and accurate diagnosis of congenital toxoplasmosis. Pediatric Infectious Disease Journal, 27, 125–129. [Google Scholar]
  6. Cook AJC, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT. 2000. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. British Medical Journal, 321, 142–147. [CrossRef] [PubMed] [Google Scholar]
  7. Dai J, Jiang M, Wang Y, Qu L, Gong R, Si J. 2012. Evaluation of a recombinant multiepitope peptide for serodiagnosis of Toxoplasma gondii Infection. Clinical and Vaccine Immunology: CVI, 19, 338–342. [Google Scholar]
  8. Dard C, Fricker-Hidalgo H, Brenier-Pinchart M-P, Pelloux H. 2016. Relevance of and new developments in serology for Toxoplasmosis. Trends in Parasitology, 32, 492–506. [CrossRef] [PubMed] [Google Scholar]
  9. Denkers EY, Gazzinelli RT. 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews, 11, 569–588. [CrossRef] [PubMed] [Google Scholar]
  10. Döşkaya M, Liang L, Jain A, Can H, Gülçe İz S, Felgner PL, Değirmenci Döşkaya A, Davies DH, Gürüz AY. 2018. Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cysts. Parasites & Vectors, 11, 393. [CrossRef] [PubMed] [Google Scholar]
  11. Drapała D, Holec-Gąsior L, Kur J. 2015. New recombinant chimeric antigens, P35-MAG1, MIC1-ROP1, and MAG1-ROP1, for the serodiagnosis of human toxoplasmosis. Diagnostic Microbiology and Infectious Disease, 82, 34–39. [CrossRef] [PubMed] [Google Scholar]
  12. Dupont CD, Christian DA, Selleck EM, Pepper M, Leney-Greene M, Harms Pritchard G, Koshy AA, Wagage S, Reuter MA, Sibley LD, Betts MR, Hunter CA. 2014. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathogens, 10, e1004047. [CrossRef] [PubMed] [Google Scholar]
  13. Fatoohi AF, Cozon GJN, Gonzalo P, Mayencon M, Greenland T, Picot S, Peyron F. 2004. Heterogeneity in cellular and humoral immune responses against Toxoplasma gondii antigen in humans. Clinical and Experimental Immunology, 136, 535–541. [CrossRef] [PubMed] [Google Scholar]
  14. Franck J, Garin YJ-F, Dumon H. 2008. LDBio-Toxo II immunoglobulin G Western Blot confirmatory test for anti-toxoplasma antibody detection. Journal of Clinical Microbiology, 46, 2334–2338. [CrossRef] [PubMed] [Google Scholar]
  15. Frenkel JK, Dubey JP. 1975. Hammondia hammondi gen. nov., sp. nov., from domestic cats, a new coccidian related to Toxoplasma and Sarcocystis. Zeitschrift für Parasitenkunde, 46, 3–12. [Google Scholar]
  16. Frenkel JK, Dubey JP. 2000. The taxonomic importance of obligate heteroxeny: distinction of Hammondia hammondi from Toxoplasma gondii – another opinion. Parasitology Research, 86, 783–786. [CrossRef] [PubMed] [Google Scholar]
  17. Gay-Andrieu F, Fricker-Hidalgo H, Sickinger E, Espern A, Brenier-Pinchart M-P, Braun H-B, Pelloux H. 2009. Comparative evaluation of the ARCHITECT Toxo IgG, IgM, and IgG Avidity assays for anti-Toxoplasma antibodies detection in pregnant women sera. Diagnostic Microbiology and Infectious Disease, 65, 279–287. [CrossRef] [PubMed] [Google Scholar]
  18. Gazzonis AL, Zanzani SA, Santoro A, Veronesi F, Olivieri E, Villa L, Lubian E, Lovati S, Bottura F, Epis S, Manfredi MT. 2018. Toxoplasma gondii infection in raptors from Italy: seroepidemiology and risk factors analysis. Comparative Immunology, Microbiology and Infectious Diseases, 60, 42–45. [CrossRef] [PubMed] [Google Scholar]
  19. Gondim LFP, Mineo JR, Schares G. 2017. Importance of serological cross-reactivity among Toxoplasma gondii, Hammondia spp., Neospora spp., Sarcocystis spp. and Besnoitia besnoiti. Parasitology, 144, 851–868. [CrossRef] [PubMed] [Google Scholar]
  20. Hajissa K, Zakaria R, Suppian R, Mohamed Z. 2017. An evaluation of a recombinant multiepitope based antigen for detection of Toxoplasma gondii specific antibodies. BMC Infectious Diseases, 17, 807. [CrossRef] [PubMed] [Google Scholar]
  21. Hiszczyńska-Sawicka E, Kur J, Pietkiewicz H, Holec-Gasior L, Gasior A, Myjak P. 2005. Efficient production of the Toxoplasma gondii GRA6, p35 and SAG2 recombinant antigens and their applications in the serodiagnosis of toxoplasmosis. Acta Parasitologica, 50, 249–254. [Google Scholar]
  22. Jones JL, Dubey JP. 2012. Foodborne toxoplasmosis. Clinical Infectious Diseases, 55, 845–851. [Google Scholar]
  23. Kahi S, Cozon GJ, Peyron F. 1999. Early detection of cellular immunity in congenitally Toxoplasma gondii-infected children. Pediatric Infectious Disease Journal, 18, 846–847. [Google Scholar]
  24. Khan K, Khan W. 2018. Congenital toxoplasmosis: an overview of the neurological and ocular manifestations. Parasitology International, 67, 715–721. [CrossRef] [PubMed] [Google Scholar]
  25. Khurana S, Batra N. 2016. Toxoplasmosis in organ transplant recipients: evaluation, implication, and prevention. Tropical Parasitology, 6, 123–128. [CrossRef] [PubMed] [Google Scholar]
  26. Laforet CK, Deksne G, Petersen HH, Jokelainen P, Johansen MV, Lassen B. 2019. Toxoplasma gondii seroprevalence in extensively farmed wild boars (Sus scrofa) in Denmark. Acta Veterinaria Scandinavica, 61, 4. [CrossRef] [PubMed] [Google Scholar]
  27. Lee S-B, Lee T-G. 2017. Toxoplasmic encephalitis in patient with acquired immunodeficiency syndrome. Brain Tumor Research and Treatment, 5, 34–36. [CrossRef] [PubMed] [Google Scholar]
  28. Liao M, Xuan X, Huang X, Shirafuji H, Fukumoto S, Hirata H, Suzuki H, Fujisaki K. 2005. Identification and characterization of cross-reactive antigens from Neospora caninum and Toxoplasma gondii. Parasitology, 130, 481–488. [CrossRef] [PubMed] [Google Scholar]
  29. Mahinc C, Flori P, Delaunay E, Guillerme C, Charaoui S, Raberin H, Hafid J, L’Ollivier C. 2017. Evaluation of a new immunochromatography technology test (LDBio diagnostics) to detect Toxoplasma IgG and IgM: comparison with the routine architect technique. Journal of Clinical Microbiology, 55, 3395–3404. [CrossRef] [PubMed] [Google Scholar]
  30. Meng Q-F, Li D, Yao G-Z, Zou Y, Cong W, Shan X-F. 2018. Seroprevalence of Toxoplasma gondii infection and variables associated with seropositivity in donkeys in eastern China. Parasite, 25, 66. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  31. Munday BL, Dubey JP. 1988. Prevention of Toxoplasma gondii abortion in goats by vaccination with oocysts of Hammondia hammondi. Australian Veterinary Journal, 65, 150–153. [CrossRef] [PubMed] [Google Scholar]
  32. Murat J-B, Dard C, Fricker Hidalgo H, Dardé M-L, Brenier-Pinchart M-P, Pelloux H. 2013. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clinical and Vaccine Immunology, 20, 1203–1212. [Google Scholar]
  33. Pomares C, Montoya JG. 2016. Laboratory diagnosis of congenital toxoplasmosis. Journal of Clinical Microbiology, 54, 2448–2454. [CrossRef] [PubMed] [Google Scholar]
  34. Prusa A-R, Kasper DC, Sawers L, Walter E, Hayde M, Stillwaggon E. 2017. Congenital toxoplasmosis in Austria: prenatal screening for prevention is cost-saving. PLoS Neglected Tropical Diseases, 11, e0005648. [CrossRef] [PubMed] [Google Scholar]
  35. Riahi H, Bouteille B, Darde ML. 1998. Antigenic similarity between Hammondia hammondi and Toxoplasma gondii tachyzoites. Journal of Parasitology, 84, 651–653. [Google Scholar]
  36. Rostami A, Karanis P, Fallahi S. 2018. Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection. Infection, 46, 303–315. [Google Scholar]
  37. Sickinger E, Gay-Andrieu F, Jonas G, Schultess J, Stieler M, Smith D, Hausmann M, Stricker R, Stricker R, Dhein J, Braun H-B. 2008. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diagnostic Microbiology and Infectious Disease, 62, 235–244. [CrossRef] [PubMed] [Google Scholar]
  38. Smets A, Fauchier T, Michel G, Marty P, Pomares C. 2016. Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women. Parasite, 23, 45. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  39. Sohn CS, Cheng TT, Drummond ML, Peng ED, Vermont SJ, Xia D, Cheng SJ, Wastling JM, Bradley PJ. 2011. Identification of novel proteins in Neospora caninum using an organelle purification and monoclonal antibody approach. PloS One, 6, e18383. [CrossRef] [PubMed] [Google Scholar]
  40. Sonneville R, Magalhaes E, Meyfroidt G. 2017. Central nervous system infections in immunocompromised patients. Current Opinion in Critical Care, 23, 128–133. [CrossRef] [PubMed] [Google Scholar]
  41. Villagra-Blanco R, Barrantes-Granados O, Montero-Caballero D, Romero-Zúñiga JJ, Dolz G. 2019. Seroprevalence of Toxoplasma gondii and Neospora caninum infections and associated factors in sheep from Costa Rica. Parasite Epidemiology and Control, 4, e00085. [CrossRef] [PubMed] [Google Scholar]
  42. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. 2016. Help in the choice of automated or semiautomated immunoassays for serological diagnosis of toxoplasmosis: evaluation of nine immunoassays by the french national reference center for toxoplasmosis. Journal of Clinical Microbiology, 54, 3034–3042. [CrossRef] [PubMed] [Google Scholar]
  43. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C. 2013. Congenital Toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clinical Infectious Diseases, 56, 1223–1231. [Google Scholar]
  44. Wallon M, Garweg JG, Abrahamowicz M, Cornu C, Vinault S, Quantin C, Bonithon-Kopp C, Picot S, Peyron F, Binquet C. 2014. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Pediatrics, 133, e601–608. [PubMed] [Google Scholar]
  45. Walzer KA, Adomako-Ankomah Y, Dam RA, Herrmann DC, Schares G, Dubey JP, Boyle JP. 2013. Hammondia hammondi, an avirulent relative of Toxoplasma gondii, has functional orthologs of known T. gondii virulence genes. Proceedings of the National Academy of Sciences of the United States of America, 110, 7446–7451. [CrossRef] [PubMed] [Google Scholar]
  46. Wang X, Qin S-Y, Liu Z-L, Zhang X-T, Cui D-Y, Li J-H, Liu Y, Zhao Q, Ni H-B. 2019. Seroprevalence and risk factors of Toxoplasma gondii infection in domestic raccoon dogs in four provinces in northern China. Microbial Pathogenesis, 128, 136–138. [CrossRef] [PubMed] [Google Scholar]
  47. Zhang X-X, Qin S-Y, Li X, Ren W-X, Hou G, Zhao Q, Ni H-B. 2018. Seroprevalence and related factors of Toxoplasma gondii in pigeons intended for human consumption in Northern China. Vector Borne and Zoonotic Diseases, 19, 302–305. [Google Scholar]
  48. Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, Acharya G. 2018. Seroepidemiological map of Toxoplasma gondii infection and associated risk factors in preconception period in China: a nationwide cross-sectional study. Journal of Obstetrics and Gynaecology Research, 44, 1134–1139. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.